HANTZ FINANCIAL SERVICES, INC.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1071061
SOUTHFIELD, MI
Position in TEVA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,419,233
+$327,052 QoQ
Shares Held
41,890
+15.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#299
of 674 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $25,049,020 across 25 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
852,184 | $7,950,876 | |
| 2 | ZTS |
Zoetis Inc.
|
81,045 | $5,823,893 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
269,650 | $4,322,489 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
41,890 | $1,419,233 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,278 | $1,234,288 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
6,706 | $1,130,229 | |
| 7 | VTRS |
Viatris Inc
|
30,373 | $482,323 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
4,265 | $473,159 |
All Filings in TEVA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,419,233 | 41,890 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,092,181 | 36,261 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,166,879 | 37,388 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $439,713 | 21,768 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $102,872 | 6,138 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $6,501 | 423 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||